Journey Medical (NASDAQ:DERM) will release its quarterly earnings report on Wednesday, 2025-11-12. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Journey Medical to report an earnings per share (EPS) of $-0.05.
The announcement from Journey Medical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Historical Earnings Performance
Last quarter the company missed EPS by $0.09, which was followed by a 15.11% drop in the share price the next day.
Here's a look at Journey Medical's past performance and the resulting price change:
| Quarter | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| EPS Estimate | -0.07 | -0.24 | -0.22 | -0.15 |
| EPS Actual | -0.16 | -0.18 | 0.08 | -0.12 |
| Price Change % | -15.00 | 19.00 | -4.00 | -6.00 |
Stock Performance
Shares of Journey Medical were trading at $8.95 as of November 10. Over the last 52-week period, shares are up 78.32%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Journey Medical visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
